{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:46:19Z","timestamp":1791895579403,"version":"4.3.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:00:00Z","timestamp":1679356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS21\/00165"],"award-info":[{"award-number":["FIS21\/00165"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["T996-B30, I4685-B (SYNABS), DOC 33-B27"],"award-info":[{"award-number":["T996-B30, I4685-B (SYNABS), DOC 33-B27"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-IgLON5 disease is a rare neurological disorder characterized by autoantibodies against IgLON5, and pathological evidence of neurodegeneration. IgLON5 is a cell adhesion molecule but its physiological function is unknown. Our aim was to investigate the IgLON5 interactome and to determine if IgLON5 antibodies (IgLON5-abs) affect these protein interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>IgLON5 interactome was investigated by mass spectrometry sequencing of proteins immunoprecipitated by IgLON5 autoantibodies using cultures of rat cerebellar granular neurons (CGNs). Shedding of IgLON5 was explored using HEK cells transfected with human IgLON5 plasmid and in CGNs. Interactions of IgLON5 with identified binding partners and IgLON5-abs effects were confirmed by immunofluorescence in transfected HEK cells and rat hippocampal neurons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients\u2019 IgLON5 antibodies co-precipitated all members of the IgLON family and three 3 additional surface proteins. IgLON5 predominantly establishes homomeric and heteromeric\n                      <jats:italic>cis<\/jats:italic>\n                      (within the cell) and\n                      <jats:italic>trans<\/jats:italic>\n                      (between cells)-interactions with other IgLON family members and undergoes spontaneous ectodomain shedding. Antibodies from patients with anti-IgLON5 disease prevent trans-interactions in hippocampal neurons independently of the IgLON5 IgG subclass distribution.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We show a potentially novel pathogenic mechanism of IgLON5-abs that consists in blocking IgLON5 interactions with its binding partners. These findings extend our knowledge about the physiological role of IgLON5 and pave the way to future understanding of the pathological mechanisms of anti-IgLON5 disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1151574","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T03:40:01Z","timestamp":1679456401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Patients\u2019 IgLON5 autoantibodies interfere with IgLON5-protein interactions"],"prefix":"10.3389","volume":"14","author":[{"given":"Jon","family":"Landa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatriz","family":"Serafim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Gaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Koneczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Hoftberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Graus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20134422(14)70051\u20131","article-title":"A novel non\u2013rapid\u2013eye movement and rapid\u2013eye\u2013movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: A case series, characterisation of the antigen, and post\u2013mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401\u2013016\u20131591\u20138","article-title":"Neuropathological criteria of anti\u2013IgLON5\u2013related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.628438","article-title":"IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth","volume":"290","author":"Sanz","year":"2015","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2015.00089","article-title":"The IgLON family member Negr1 promotes neuronal arborization acting as soluble factor via FGFR2","volume":"8","author":"Pischedda","year":"2015","journal-title":"Front Mol Neurosci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974\u2013016\u20130689\u20131","article-title":"Cellular investigations with human antibodies associated with the anti\u2013IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25857","article-title":"Effects of IgLON5 antibodies on neuronal cytoskeleton: A link between autoimmunity and neurodegeneration","volume":"88","author":"Landa","year":"2020","journal-title":"Ann Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102646","article-title":"Update on IgG4\u2013mediated autoimmune diseases: New insights and new family members","volume":"19","author":"Koneczny","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25829","article-title":"NMDAR antibodies alter dopamine receptors and cause psychotic behavior in mice","volume":"88","author":"Carceles\u2013Cordon","year":"2020","journal-title":"Ann Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26098","article-title":"Encephalitis with autoantibodies against the glutamate kainate receptors GluK2","volume":"90","author":"Landa","year":"2021","journal-title":"Ann Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti\u2013IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac090","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti\u2013IgLON5 disease","volume":"8","author":"Gr\u00fcter","year":"2022","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1984-10.2010","article-title":"Cellular\/Molecular synaptic localization and activity of ADAM10 regulate excitatory synapses through n\u2013cadherin cleavage","volume":"30","author":"Malinverno","year":"2010","journal-title":"J Neurosci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.brainres.2010.12.028","article-title":"DIgLONs inhibit initiation of neurite outgrowth from forebrain neurons via an IgLON\u2013containing receptor complex","volume":"1374","author":"Akeel","year":"2011","journal-title":"Brain Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy190","article-title":"NEGR1 and FGFR2 cooperatively regulate cortical development and core behaviours related to autism disorders in mice","volume":"141","author":"Szczurkowska","year":"2018","journal-title":"Brain"},{"key":"B16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/neu.10050","article-title":"Complementary expression and heterophilic interactions between igLON family members neurotrimin and LAMP","volume":"51","author":"Gil","year":"2002","journal-title":"J Neurobiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.024703","article-title":"Kidins220\/ARMS modulates the activity of microtubule\u2013regulating proteins and controls neuronal polarity and development","volume":"285","author":"Higuero","year":"2010","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12758","article-title":"The expanding field of IgG4\u2013mediated neurological autoimmune disorders","volume":"22","author":"Huijbers","year":"2015","journal-title":"Eur J Neurology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy253","article-title":"LGI1 antibodies alter K v 1.1 and AMPA receptors changing synaptic excitability, plasticity and memory","volume":"141","author":"Petit\u2013Pedrol","year":"2018","journal-title":"Brain"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26345","article-title":"Human CASPR2 antibodies reversibly alter memory and the CASPR2 protein complex","volume":"91","author":"Joubert","year":"2022","journal-title":"Ann Neurol"}],"updated-by":[{"DOI":"10.3389\/fimmu.2023.1233632","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1151574\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T15:10:27Z","timestamp":1688137827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1151574\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":20,"alternative-id":["10.3389\/fimmu.2023.1151574"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1151574","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]},"article-number":"1151574"}}